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The inflammasome is a large multiprotein complex whose assembly leads to the activation of caspase-1,
which promotes the maturation of proinflammatory cytokines interleukin-1b (IL-1b) and IL-18. Proteins
encoded by the nucleotide-binding domain and leucine-rich repeat (NLR) containing gene family form the
central components of inflammasomes and act as intracellular sensors to detect cytosolic microbial compo-
nents and ‘‘danger’’ signals (such as ATP and toxins). The inflammasome not only plays a pivotal role in innate
immune responses toward pathogens but alsomediates the activity of aluminum adjuvants. Thus, the inflam-
masome and associated signaling pathways are attractive targets for new therapeutics and vaccines.Introduction
Throughout evolution, eukaryotic hosts and pathogens have en-
gaged in a constant tug of war, with the eukaryotic host evolving
an arsenal of defense mechanisms to recognize and overcome
infections. Eukaryotic cells can discriminate ‘‘microbial for-
eigners’’ from ‘‘self’’ through the immune-recognition system
that recognizes various evolutionarily conserved microbial com-
ponents called pathogen-associated molecular patterns
(PAMPs), such as lipopolysaccharide (LPS), lipoproteins, lipotei-
choic acid (LTA), peptidoglycan (PGN), and flagellin (Medzhitov,
2001). The recognition of different PAMPS is achieved by
a number of germline-encoded pattern-recognition receptors
(PRRs) of which the membrane-bound Toll-like receptors
(TLRs) are the best studied. Although TLRs recognize PAMPs
on the cell surface or within endosomes, a newly discovered
class of proteins encoded by the nucleotide-binding domain
and leucine-rich repeat containing gene family (NLR) is capable
of recognizing PAMPs in intracellular compartments (Akira
et al., 2006; Meylan et al., 2006; Ting et al., 2008). Both TLR-
and NLR-mediated recognition of PAMPs leads to the activation
of host cell signaling pathways and subsequent innate and
adaptive immune responses. Unlike the TLR-mediated signaling
pathways, much less is understood about the NLR-mediated
signaling pathways involved in host immune responses.
Most NLRs consist of three domains: an N-terminal region in-
cluding protein interaction domains such as the caspase recruit-
ment domain (CARD), pyrin domain (PYD), and baculovirus IAP
(inhibitor of apoptosis protein) repeat (BIR); an intermediary
NOD domain; and a C-terminal leucine-rich repeat (LRR)
domain. The LRR domain is thought to fold back onto the NOD
domain to autoinhibit NLR activation and may function as the
sensor that detects the presence of cytosolic microbial compo-
nents (Kanneganti et al., 2007b; Martinon and Tschopp, 2005).
The first identified NLRswere NOD1 and NOD2, which recognize
the bacterial peptidoglycan fragments dipeptide g-D-glutamyl-
meso-diaminopimelic acid (iE-DAP) and muramyl dipeptide
(MDP), respectively (Chamaillard et al., 2003; Girardin et al.,
2003). Stimulation of NOD1 or NOD2 induces activation of198 Cell Host & Microbe 4, September 11, 2008 ª2008 Elsevier IncNF-kB and MAP kinase pathways, which in turn upregulate the
production of proinflammatory and antimicrobial molecules,
contributing to the host immune response.
In contrast, many other NLRs respond to a myriad of stimuli
and form a complex with caspase-1 (previously known as inter-
leukin-1b [IL-1b]-converting enzyme [ICE]) and an adaptor pro-
tein ASC (apoptosis-associated speck-like protein containing
a CARD domain) that leads to the activation of caspase-1 (Maria-
thasan and Monack, 2007). Tschopp and colleagues first named
this caspase-activating complex the inflammasome (Martinon
et al., 2002). The NLRs involved in the assembly of the inflamma-
some complex include NALPs (NACHT-, LRR-, and pyrin-
domain-containing proteins), NLRC4 (ICE-protease activating
factor or CARD12), and NAIPs (neuronal apoptosis inhibitor
proteins) (Mariathasan and Monack, 2007). The name of each
inflammasome is designated by the NLR within it, such as the
NLRP1 (NALP1) inflammasome, the NLRP3 (NALP3) inflamma-
some, and the NLRC4 (IPAF) inflammasome. A complete list of
NLRs can be found in the review by Ting et al. (2008). The central
effector protein of the inflammasome, caspase-1, promotes the
processing of pro-IL-1b and pro-IL-18 into their mature forms
(IL-1b and IL-18, respectively), both of which help to recruit
inflammatory cells to sites of infection (Li et al., 1995; Martinon
and Tschopp, 2004). Caspase-1 is also required for the matura-
tion of IL-33, a T helper type 2 (TH2)-associated cytokine
(Schmitz et al., 2005). In addition, caspase-1 cleaves other cellu-
lar substrates and mediates unconventional protein secretion,
contributing to its prodeath and proinflammatory activities,
respectively (Keller et al., 2008; Shao et al., 2007). Within the
inflammasome, caspase-1 and NLRs are thought to be linked
via the adaptor protein ASC. ASC contains an N-terminal PYD
domain and a C-terminal CARD domain, both of which enable
ASC to recruit other PYD- and CARD-containing proteins
through homotypic protein-protein interactions (Mariathasan
and Monack, 2007). Studies have shown that depletion of ASC
from the inflammasome or expression of a dominant-negative
form of ASC in THP-1 cells blocks LPS-stimulated caspase-1 ac-
tivation and IL-1b secretion (Martinon et al., 2002). However,.
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et al. showed that caspase-1 activation by NLRP1 does not
require but is enhanced by ASC (Faustin et al., 2007). Although
these studies suggest that ASC is an adaptor protein or activity
enhancer of the inflammasome, it should be noted that ASC
can also self-associate through its PYD domain to form the
ASC pyroptosome (a large supramolecular assembly of ASC)
and activate caspase-1 (Fernandes-Alnemri et al., 2007).
The inflammasomeplays an important role in inflammatory dis-
eases. For instance, the deregulation of NLRP3 inflammasome
activation caused by a gain-of-function mutation of NLRP3
(NALP3/cryopyrin/CIAS) is associated with hereditary periodic-
fever syndromes: Muckle-Wells syndrome (MWS), familial cold
autoinflammatory syndrome (FCAS), and neonatal-onset multi-
system inflammatory disease (NOMID) (Agostini et al., 2004;
Aksentijevich et al., 2002; Feldmann et al., 2002; Hoffman et al.,
2001).Macrophages frompatientswith these syndromes secrete
IL-1b and IL-18 even in the absence of a stimulus. In these
patients, the NLRP3 inflammasome is hyperactivated, and the
excessive activity induces constitutive activation of caspase-1,
promoting the maturation of pro-IL-1b (Agostini et al., 2004).
TheNLRP3 inflammasomehas since been reported to be a highly
conserved component for recognizing microorganisms (Kanne-
ganti et al., 2006;Mariathasan et al., 2006). Similar toNLRP3, var-
iants of NLRP1 and NLRP12 are associated with vitiligo-related
multiple autoimmune disease and hereditary periodic-fever
syndromes, respectively (Jeru et al., 2008; Jin et al., 2007).
This review aims to summarize the recent advances in the
understanding of the central role of inflammasome activation in
innate defense against pathogen infections and danger signals
(such as ATP and toxins) and in modulating adaptive immunity.
One of the goals which we are involved in (as part of the Grand
Challenges in Global Health initiative supported by the Bill & Me-
lindaGates Foundation) is to explore new strategies to overcome
drug resistance by seeking to boost the host’s innate immunity
rather than targeting specific disease-causing organisms. We
believe that such an approach makes it more difficult for mi-
crobes to develop resistance. The inflammasome is an emerging
and rapidly progressing research focus in the field of innate im-
munity and serves as a good example of how innate immunity
may serve as a tipping point for disease outcome, a balance
which we can exploit as a way to treat diseases without fostering
drug resistance.
PAMPs, DAMPs, and Inflammasome Activation
IL-1b, produced by activated macrophages and monocytes, is
one of the key players in the innate immune response. Two dis-
tinct signals are required for the production and secretion of IL-
1b (Figure 1). The first signal comes from various extracellular or
endosomal PAMPs, such as LPS (a TLR4 agonist), lipoteichoic
acid (a TLR2 agonist), CpG dinucleotides (a TLR9 agonist), the
lipopeptide Pam3CysSerLys4 (Pam3CSK4, a TLR2 agonist),
and R848 (a TLR7 agonist), which induce the synthesis of pro-
IL-1b by engaging their specific TLRs (Mariathasan andMonack,
2007). The second signal provided by different danger associ-
ated molecular patterns (DAMPs) activates the inflammasome,
resulting in the catalytic processing of the 45 kDa pro-cas-
pase-1 into its enzymatically active form, a heterodimer com-
posed of subunits p20 and p10 (Martinon et al., 2002). TheseDAMPs include molecules such as extracellular ATP, gout-asso-
ciated uric acid crystals-monosodium urate (MSU), and calcium
pyrophosphate dihydrate (CPPD), all of which signal through the
NLRP3 inflammasome to activate caspase-1 (Mariathasan et al.,
2006; Martinon et al., 2006). However, two different mechanisms
are implicated in MSU-, CPPD-, and ATP-stimulated caspase-1
activation. MSU- or CPPD-stimulated caspase-1 activation
requires their endocytosis by macrophages, as evidenced by
a study in which an endocytosis inhibitor (colchicines) prevented
the MSU- and CPPD-induced maturation of IL-1b (Martinon
et al., 2006). In contrast, ATP-stimulated caspase-1 activation
requires the engagement of ATPwith a purinergic P2X7 receptor,
and colchines did not affect the activation of IL-1b by ATP
(Martinon et al., 2006; Solle et al., 2001; Surprenant et al.,
1996). Although both endocytosis-dependent and -independent
processes have been involved in the activation of the same
inflammasome, it remains to be determined whether these two
processes converge on a common signaling pathway (such as
potassium efflux, see below) to activate the inflammasome.
In addition to MSU, CPPD, and ATP, other danger signals,
such as toxins and crystalline structures, can also activate the
inflammasome (Figure 1). Different pore-forming toxins, such
as nigericin, maitotoxin and aerolysin, have been shown to trig-
ger NLRP3 inflammasome-dependent caspase-1 activation
(Gurcel et al., 2006; Mariathasan et al., 2006). Notably, the study
byGurcel et al. reported that activation of caspase-1 by aerolysin
led to the activation of sterol regulatory element binding proteins
(SREBPs) and enhanced cell viability (Gurcel et al., 2006). The
same study also showed that inhibition of caspase-1 or knock-
down of inflammasome components increased aerolysin-
induced cell death (Gurcel et al., 2006). These results suggest
that toxin-induced caspase-1 activation not only plays a well-
established role in processing of pro-IL-1b to trigger inflamma-
tion but also helps promote cell survival. It is believed that
toxin-induced membrane permeabilization and the resulting de-
pletion of cytoplasmic potassium is the trigger for toxin-induced
inflammasome activation.
Crystalline structures are another type of inflammasome-
activating substance that were recently characterized. The first
report by Dostert et al. studied the role of two airborne pollutants
(asbestos and silica) in activating IL-1b secretion (Dostert et al.,
2008). Asbestos or silica have long been known to induce inflam-
matory responses and are one of the major causes of pulmonary
fibrosis and lung cancer (Mossman and Churg, 1998). Using an
asbestos-inhalation model, Dostert et al. demonstrated that
mice deficient in NLRP3 showed decreased recruitment of in-
flammatory cells to the lungs and reduced secretion of IL-1b
and KC (a neutrophil chemoattractant) when exposed to asbes-
tos (Dostert et al., 2008). Furthermore, knockdown of NLRP3,
ASC, or caspase-1 in human macrophages inhibited asbestos-
and silica-induced secretion of IL-1b (Dostert et al., 2008). The
important role played by the NLRP3 inflammasome in the innate
immune response to airborne pollutants was soon confirmed in
a separate study by Cassel et al. (Cassel et al., 2008). The mech-
anism underlying asbestos-stimulated inflammasome activation
could possibly arise from ineffective phagocytosis by macro-
phages, followed by generation of reactive oxygen species
(ROS) (Dostert et al., 2008). This mechanism is supported by
the fact that inhibitors of ROS and the endocytotic pathwayCell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Inc. 199
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ReviewFigure 1. Activation of the Inflammasome by PAMPs and DAMPs
The inflammasome consists of the nucleotide-binding domain and leucine-rich repeat containing protein (NLR), ASC (apoptosis-associated speck-like protein
containing a caspase recruitment domain), and pro-caspase-1. ASC bridges NLR and pro-caspase-1. The name of each inflammasome is designated by the NLR
within it, such as the NLRP1 inflammasome, the NLRP3 inflammasome, and the NLRC4 inflammasome. Extracellular PAMPs promote pro-IL-1b synthesis by
engaging the TLR-NF-kB pathway. They can also be delivered into host cell cytosol via pores formed by ATP- P2X7R-activated pannexin-1. Unlike extracellular
PAMPs, different cytosolic PAMPs are able to activate distinct inflammasomes. For example, cytosolic flagellin and LPS activate the NLRC4 and NLRP3 inflam-
masomes, respectively, whereas cytosolic MDP activates NLRP3 and NLRP1 inflammasomes. NOD2 and NLRP1 associate with each other in response toMDP.
DAMPs, such as ATP, toxins, and crystals, can induce NLRP3 inflammasome activation. ATP-P2X7R-mediated activation of pannexin-1 leads to NLRP3 inflam-
masome activation. Themechanisms of how other DAMPs activate inflammasomes are summarized in Figure 2. Inflammasome activation triggers the processing
of pro-caspase-1 into its mature form, caspase-1. Active caspase-1 induces cell death and the processing of proinflammatory cytokine pro-IL-1b into IL-1b,
which is secreted out of the cell. As an exception, however, aerolysin-induced caspase-1 activation upregulates SREBPs, which promote cell survival. PAMPs,
pathogen associated molecular patterns; DAMPs, danger associated molecular patterns; P2X7R, a purinergic receptor; LPS, lipopolysaccharide; MDP, muramyl
dipeptide; SREBPs, sterol regulatory element binding proteins.were able to prevent asbestos- and silica-induced IL-1b secre-
tion (Cassel et al., 2008; Dostert et al., 2008).
Although PAMPs are generally regarded as the first signal
required for the stimulation of pro-IL-1b production, certain
PAMPs also provide the second signal that activates inflamma-
somes to secrete IL-1b (Figure 1). MDP induces inflammasome
activation through different NLRs, namely NLRP1, NOD2, and
NLRP3 (Faustin et al., 2007; Martinon et al., 2004; Pan et al.,
2007). The effects of MDP on NLRP3 are likely to act through
the LRR domain (Martinon et al., 2004), although there has
been no evidence of direct physical interaction between MDP
and NLRP3. MDP stimulation can also cause the association of
NOD2 with NLRP1 and caspase-1, leading to the activation of
caspase-1 and IL-1b secretion (Hsu et al., 2008), suggesting
that NLRP1 may mediate MDP-induced caspase-1 activation
through its interaction with NOD2. However, it should be noted
that MDP can induce NLRP1-mediated caspase-1 activation in
a minimal in vitro system, and no additional protein cofactors
are required (Faustin et al., 2007). It remains unclear whether
both NLRP1 and NOD2 directly interact with MDP to activate
caspase-1. In addition to MDP, flagellin and LPS are also able
to activate the inflammasome via different NLRs. Flagellin,
when delivered into the host cell cytosol by transfection, acti-200 Cell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Incvates caspase-1 and IL-1b secretion via the NLRC4 inflamma-
some (Franchi et al., 2006; Miao et al., 2006). In contrast, LPS,
when delivered into the host cell cytosol in the presence of
a pore-forming molecule streptolysin O (SLO), induces the acti-
vation of caspase-1 via the NLRP3 inflammasome (Kanneganti
et al., 2007a). Most of these studies used murine macrophages
to demonstrate that cytosolic PAMPs are required for activation
of the inflammasome. However, extracellular PAMPs alone have
been shown to be sufficient for inflammasome activation in
primary human monocytes (Picciniet al., 2008). Piccini et al.
showed that extracellular PAMPs, such as LPS, MDP, zymosan,
and flagellin, induced not only the production of pro-IL-1b by en-
gaging the TLR-NF-kB pathway but also the extracellular release
of endogenous ATP from human monocytes that could activate
the P2X7 receptor, leading to ATP-P2X7R-mediated caspase-1
activation and IL-1b secretion (Piccini et al., 2008). The involve-
ment of this extended signaling pathway suggests that the
regulation of IL-1b secretion in human monocytes is much
more complex than previously thought.
Triggering of Inflammasome Activation by Pathogens
During host-pathogen interactions, pathogens can release their
virulence factors and/or PAMPs into the host cell cytosol by.
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cretion of channel-forming toxins, such as Staphylococcus au-
reus a-toxin and Escherichia coli hemolysin, which form pores
in the host cell membrane (Aroian and van der Goot, 2007).
These pores facilitate the entry of bacteria into the host cell cy-
tosol (Aroian and van der Goot, 2007). Two bacterial secretion
systems, the type III and type IV secretion systems (T3SS and
T4SS, respectively) encoded by Gram-negative bacteria, are
able to form pores (or channels) in the host membrane via their
translocon components (Hueck, 1998). These pores mediate
the translocation of virulence factors (such as effector proteins)
or peptidoglycan fragments into the host cell cytosol (Monack
et al., 2001; Viala et al., 2004). On the other hand, PAMPs can
enter the host cell cytosol through the digestion of intracellular
and phagocytosed pathogens by host hydrolases. The entry of
microbial virulence factors and PAMPs into the host cell cytosol
rapidly activates the host immune surveillance system and
triggers a series of host immune responses. One such immune
surveillance system is the inflammasome that detects cytosolic
PAMPs released by various pathogens or certain cellular signals
induced by microbial virulence factors and/or PAMPs (Kanne-
ganti et al., 2007b; Mariathasan and Monack, 2007; Pe´trilli
et al., 2007a). There are both common and unique inflamma-
some components involved in sensing different pathogens.
The following section summarizes virulence factors, PAMPs,
and various inflammasome components involved in host-patho-
gen interactions (Table 1).
NLRC4 Inflammasome Activation
Many Gram-negative bacteria, such as Salmonella typhimurium,
Pseudomonas aeruginosa, Shigella flexneri, and Legionella
pneumophila, can induce caspase-1 activation and rapidmacro-
phage cell death (Table 1). Macrophages deficient in caspase-1
are resistant to cell death induced by these bacteria (Miao et al.,
Table 1. Virulence Factors, PAMPs, and Inflammasomes
Involved in Host-Pathogen Interaction
Pathogens
Virulence Factors,
PAMPs Inflammasomes (NLRs)
S. typhimurium T3SS, flagellin NLRC4
P. aeruginosa T3SS, flagellin NLRC4
P. aeruginosa ExoUa
L. pneumophila T4SS, flagellin NLRC4
L. pneumophila T4SS, flagellin NAIP5
S. flexneri T3SS NLRC4
M. marinum ESX-1 NLRP3
M. bovis Zmp1a
F. tularensis FPI (T6SS?) Unknown
F. tularensis FTT0748,a FTT0584a
B. anthracis Lethal toxin NLRP1, NOD2
S. aureus Toxin? NLRP3
L. monocytogenes LLO, flagellin NLRC4
L. monocytogenes LLO NLRP3
L. monocytogenes LLO Unknown
Poxvirus M13La Unknown
aVirulence factors that inhibit inflammasome activation.C2008; Monack et al., 2001; Ren et al., 2006; Suzuki et al., 2007).
This caspase-1-dependent cell death, named pyroptosis, is an
inflammatory process of cellular self-destruction that causes
cell lysis and the secretion of IL-1b and IL-18 (Fink and Cookson,
2007).
S. typhimurium-, P. aeruginosa-, and S. flexneri-induced
pyroptosis all depend on a functional T3SS, which is a common
virulence factor among these bacteria. In S. typhimurium, this
T3SS is encoded on Salmonella pathogenicity island (SPI)1
(Monack et al., 2001). Mutants deficient in translocon compo-
nents but not effector proteins secreted by these T3SSs harbor
nonfunctional T3SSs and fail to induce caspase-1 activation
and host cell death (Franchi et al., 2006, 2007; Mariathasan
et al., 2004; Sutterwala et al., 2007; Suzuki et al., 2007). In addi-
tion to T3SS, flagellin is also required for both S. typhimurium-
and P. aeruginosa-induced pyroptosis (Franchi et al., 2006,
2007; Miao et al., 2006, 2008). A study by Miao et al. showed
that merely adding the flagellin protein into the culture medium
during S. typhimurium infection could not complement flagel-
lin-deficient mutants for caspase-1-mediated macrophage cell
death (Miao et al., 2006), suggesting that cytosolic flagellin is re-
quired for caspase-1 activation during S. typhimurium infection.
Indeed, delivery of S. typhimurium flagellin into the host cell
cytosol is sufficient to induce caspase-1 activation (Franchi
et al., 2006; Miao et al., 2006). It has been suggested that the
S. typhimurium flagellin may be accidentally delivered into the
host cell cytosol through a channel formed by SPI1 translocon
components or translocon component-induced pore formation
on the phagosome membrane (Franchi et al., 2006). As with S.
typhimurium, it is likely flagellin fortuitously gains access into
the host cell cytosol via the same mechanism during P. aerugi-
nosa infection. Such secretion of flagellin into the host cell cyto-
sol may be an ‘‘error’’ that can be capitalized on by the host to
activate caspase-1 (Miao et al., 2006).
Besides T3SS and flagellin, the host factor NLRC4 is also
required for activation of caspase-1 by S. typhimurium or P. aer-
uginosa (Franchi et al., 2006; Miao et al., 2006; Sutterwala et al.,
2007). Cytosolic delivery of S. typhimurium or P. aeruginosa
flagellin by transfection could induce caspase-1 activation in
both wild-type and TLR5 (a flagellin receptor) -deficient macro-
phages, but failed to activate caspase-1 in NLRC4-deficient
macropages (Franchi et al., 2006; Miao et al., 2006, 2008). This
suggests that flagellin-induced caspase-1 activation is indepen-
dent of TLR5, and NLRC4 could be the sensor of cytosolic flagel-
lin to mediate caspase-1 activation. Therefore, TLR5 and NLRC4
are two different sensors that respond to extracellular and cyto-
solic flagellin, respectively, enabling the host to mount effective
immune responses against S. typhimurium or P. aeruginosa in-
fections. However, it is unknown whether NLRC4 binds directly
to flagellin, and the mechanism by which NLRC4 senses flagellin
remains elusive. It should be noted that flagellin may be only one
of many factors capable of independently activating the NLRC4
inflammasome. A study by Sutterwala et al. has showed that
flagellin-deficient P. aeruginosa is still capable of activating
NLRC4-dependent casapase-1 activation (Sutterwala et al.,
2007). Flagellin-deficient S. typhimurium is also able to induce
small amounts of IL-1b secretion by macrophages at a high mul-
tiplicity of infection (Miao et al., 2006), although this study did not
investigate whether the IL-1b secretion was NLRC-4 dependent.ell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Inc. 201
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lated bacterium that does not produce any flagellin. Nonethe-
less, S. flexneri-induced caspase-1 activation is also dependent
on NLRC4 (Suzuki et al., 2007). It is possible that S. flexneri de-
livers unknown microbial molecules into the host cell cytosol via
its T3SS or releases unknown microbial molecules while in the
host cell cytosol. These microbial molecules and S. typhimu-
rium-derived cytosolic flagellin are likely to induce a common
cellular stress signal that is detected by NLRC4.
L. pneumophila is an intracellular pathogen that causes a se-
vere type of pneumonia called Legionnaires’ disease. It utilizes
a T4SS (Dot/Icm secretion apparatus, which is functionally sim-
ilar to the T3SS) to translocate multiple substrates into the host
cell cytosol (Luo and Isberg, 2004). Infection by this bacterium
triggers caspase-1 activation, IL-1b secretion, and host cell
death, leading to growth restriction of L. pneumophila in host
cells (Molofsky et al., 2006; Ren et al., 2006; Zamboni et al.,
2006). A functional T4SS and flagellin are both required for
L. pneumophila-induced caspase-1 activation and IL-1b secre-
tion (Molofsky et al., 2006; Ren et al., 2006; Zamboni et al.,
2006). In particular, flagellin-deficient mutants are unable to in-
duce caspase-1-dependent macrophage cell death and can
replicate intracellularly more efficiently than wild-type bacteria
(Ren et al., 2006). It was also demonstrated that NLRC4 was im-
portant for L. pneumophila growth restriction, as NLRC4-defi-
cient macrophages showed no caspase-1 activation and failed
to restrict the replication of L. pneumophila (Zamboni et al.,
2006). Collectively, these data suggest that L. pneumophila fla-
gellin, after being delivered into the host cell cytosol via the
T4SS, activates the NLRC4 inflammasome that triggers cas-
pase-1-dependent cell death.
L. pneumophila-induced cell death also requires NAIP5 (also
called baculoviral IAP repeat-containing 1e), an NLR protein
structurally similar to NLRC4 (Kanneganti et al., 2007b). The
role of NAIP5 in the activation of caspase-1, however, remains
controversial. Previous studies showed that, when infected with
L. pneumophila, NAIP5-sufficient macrophages showed higher
activation of caspase-1, IL-1b secretion, anda higher percentage
of cell death than NAIP5-deficient macrophages (Molofsky et al.,
2006; Ren et al., 2006; Zamboni et al., 2006). However, amore re-
cent study suggests that NAIP5 is not required for activation of
caspase-1 (Lamkanfi et al., 2007). Although different experimen-
tal approaches may account for the discrepancies among these
studies, they nonetheless support that NAIP5 restricts L. pneu-
mophila growth in macrophages. The NAIP5-mediated signaling
pathway and NLRC4-mediated caspase-1 activation may there-
fore act in concert to restrict L. pneumophila growth in macro-
phages (Lamkanfi et al., 2007; Vinzing et al., 2008).
NLRP3 Inflammasome Activation
The NLRP3 inflammasome is triggered by several Gram-positive
bacteria such as L. monocytogenes, S. aureus and Mycobacte-
rium marinum to activate caspase-1 and IL-1b secretion (Koo
et al., 2008; Mariathasan et al., 2006). NLRP3- or ASC-deficient
macrophages infected with these bacteria did not show
caspase-1 activation and secreted much less IL-1b than did
wild-type macrophages (Mariathasan et al., 2006).
L. monocytogenes is an intracellular pathogen that replicates
in host cells and secretes a cholesterol-dependent pore-forming202 Cell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Inc.toxin called listeriolysin O (LLO). LLO, a major virulence factor of
L. monocytogenes, blocks phagosome-lysosome fusion and
promotes the escape of L. monocytogenes from the phagosome
to the cytoplasm (Birmingham et al., 2008). Mutants deficient in
LLO failed to induce caspase-1 activation and IL-1b secretion
(Mariathasan et al., 2006; Warren et al., 2008), indicating that
only cytosolic L. monocytogenes is able to induce caspase-1
activation. Recently, Warren et al. showed that L. monocyto-
genes-induced caspase-1 activation not only involves NLRP3
but also NLRC4 and another unknown NLR (Warren et al.,
2008). They demonstrated that although NLRP3 was the domi-
nant caspase-1 activator in the early stages of L. monocyto-
genes infection, the contribution of NLRC4 to caspase-1 activa-
tion increased gradually during the course of infection (Warren
et al., 2008). This is the first study to show the involvement of
multiple NLRs in the activation of caspase-1 during bacterial in-
fection. With more inflammasomes being characterized, we may
find that the involvement of multiple inflammasomes in the acti-
vation of caspase-1 represents a general strategy employed by
the host to combat various bacterial infections at different stages
of infection.
Unlike L. monocytogenes, the nature of toxins required for
S. aureus- orM.marinum-induced caspase-1 activation remains
unclear. In S. aureus, deletion of a-, b-, or g-toxin did not affect
S. aureus-induced caspase-1 activation (Mariathasan et al.,
2006), indicating that either a combination of these toxins or
other toxins are likely required for S. aureus-induced caspase-
1 activation. In M. marinum, a secretion system called ESX-1 is
required for mycobacterial cytolytic activity toward host cells
(Koo et al., 2008). Although the cytolysin secreted by ESX-1
has yet to be identified, it is likely to be required for M. mari-
num-induced inflammasome activation and IL-1b activation
(Koo et al., 2008).
NLRP1 Inflammasome Activation
Bacillus anthracis lethal toxin (LT) is the major cause of anthrax
pathogenesis. It consists of two proteins, protective antigen
(PA) and lethal factor (LF). PA binds to cell surface receptors
facilitating the endocytosis of LT and subsequent translocation
of LF from the endosome into the cytosol (Fink and Cookson,
2007). One particular effect of LT treatment on macrophages is
the induction of cell death, which requires the activation of cas-
pase-1 (Boyden and Dietrich, 2006; Fink et al., 2008). It is known
that macrophages from different inbred mouse strains exhibit
variable susceptibility to LT-induced cell death (Roberts et al.,
1998). Recently, Boyden and Dietrich revealed that the Nlrp1b/
Nalp1b gene underlies the variable susceptibility of thesemacro-
phages to LT-induced cell death (Boyden and Dietrich, 2006).
They have identified five Nlrp1b alleles, two of which were sus-
ceptible alleles and present in LT-susceptible mice (Boyden
and Dietrich, 2006). They further showed that LT-susceptible
macrophages treated with Nlrp1b antisense morpholinos be-
came resistant to LT-induced cell death; whereas LT-resistant
macrophages carrying the Nlrp1b susceptible allele became
sensitive to LT-induced cell death (Boyden and Dietrich, 2006).
Collectively, these data indicate that NLRP1 is required for LT-
induced cell death.
Consistent with this report, a recent study by Hsu et al.
showed that NLRP1 plays a crucial role in the innate immune
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cis can induce caspase-1-dependent IL-1b secretion, as indi-
cated by the fact that wild-type macrophages exhibited much
higher IL-1b secretion than caspase-1-deficient macrophages
in response to B. anthracis (Hsu et al., 2008). Second, B. anthra-
cis-induced IL-1b secretion is LT dependent, as an LT-deficient
mutant induced less secretion of IL-1b bymacrophages than did
wild-type bacteria. Finally, the knockdown of NLRP1 in THP-1-
derived macrophages decreased the secretion of IL-1b induced
byB. anthracis (Hsu et al., 2008). Together, these results suggest
that NLRP1 plays an important role in B. anthracis-induced IL-1b
secretion. Interestingly, the same study revealed that NOD2 was
also required for B. anthracis-induced IL-1b secretion, and it is
proposed that NOD2 and NLRP1 may associate in a single
inflammasome complex in response to B. anthracis (Hsu et al.,
2008). This putative association adds a layer of complexity to
our current understanding of how inflammasomes activate cas-
pase-1 in response to bacterial infections because the formation
of multiple NLR-activated inflammasomes (as with L. monocyto-
genes) or an inflammasome composed of two or more NLRs
(as with B. anthracis) may be responsible for the activation of
caspase-1.
Inflammasome Activation by Unknown NLRs
The Gram-negative bacterium Francisella tularensis is the caus-
ative agent of the zoonotic disease tularemia. The pathogenesis
of F. tularensis involves the bacterium escaping from the mem-
brane-bound phagosome into the cytoplasm, where it replicates
inside macrophages (Nano et al., 2004). The replication of F. tu-
larensis requires the Francisella pathogenicity island (FPI), which
has been recently recognized to encode a type VI secretion sys-
tem (T6SS) that may be able to puncture the host cell and trans-
locate effector proteins into the host cell cytosol (Cascales,
2008; Nano et al., 2004). Macrophages infected with F. tularensis
undergo a rapid caspase-1-dependent cell death (Henry et al.,
2007). In contrast, mutants devoid of FPI genes or mglA (a pos-
itive regulator of FPI) may not contain a functional T6SS, and they
are unable to escape from the macrophage phagosome to
induce cell death (Brotcke et al., 2006; Henry et al., 2007; Maria-
thasan et al., 2005), suggesting that the survival and/or replica-
tion of F. tularensis in the host cell cytosol is essential for F. tular-
ensis-induced caspase-1 activation. It was shown that F.
tularensis-induced caspase-1 activation requires ASC but not
NLRC4 (Mariathasan et al., 2005). Because ASC is usually the
bridge between caspase-1 and an NLR in the inflammasome,
more work is needed to identify the NLRs involved in F. tularen-
sis-induced caspase-1 activation. Interestingly, Henry et al.
showed that type I interferon (IFN) signaling was also required
for F. tularensis-induced caspase-1 activation (Henry et al.,
2007), but it remains to be determined how type I IFN signaling
activates the inflammasome.
Inhibition of Inflammasome Activation by Pathogens
With inflammasome-dependent activation of caspase-1 being
used as a host defense strategy against pathogenic infections,
it is not surprising, and even expected, that some pathogens
will evolve mechanisms to circumvent this defense strategy in
order to ensure their own survival and replication in host cells. Al-
though some studies have been published on how pathogensCmight inhibit inflammasome activation, this is a field that is still
in its infancy.
Myxoma virus (MV), a rabbit-specific poxvirus, is the etiologi-
cal agent of myxomatosis. It carries a pyrin domain-containing
protein called M13L, which interacts and colocalizes with ASC
(Johnston et al., 2005). It was initially thought that M13L may
activate the inflammasome by recruiting ASC via PYD domain-
mediated homotypic interaction. Surprisingly, overexpression
of M13L in differentiated THP-1 cells resulted in decreased
LPS-induced caspase-1 activation (Johnston et al., 2005). This
observation suggests that M13L may actually compete with
other pyrin-containing NLRs to bind to ASC and inhibit, rather
than activate, the inflammasome. In addition, an MV mutant
deficient in M13L was attenuated in rabbits and induced higher
levels of IL-1b than the wild-type (Johnston et al., 2005),
suggesting that MV uses M13L to circumvent host immune
responses.
Like M13L, ExoU, a T3SS effector secreted by P. aeruginosa,
is able to inhibit the activation of caspase-1 even though this pro-
tein does not contain a pyrin domain (Sutterwala et al., 2007).
ExoU is a phospholipase, and chemical or genetic inhibition of
ExoU phospholipase activity enhances P. aeruginosa-induced
caspase-1 activation (Sutterwala et al., 2007), suggesting that
the phospholipase activity of ExoU is required for ExoU-medi-
cated suppression of caspase-1 activation. Other virulence fac-
tors that inhibit inflammasome activation include F. tularensis
proteins FTT0748 and FTT0584, as well as a Zn2+ metallopro-
tease encoded by zmp1 inM. tuberculosis andM. bovis (Master
et al., 2008; Weiss et al., 2007). Mutants deficient in these viru-
lence factors induced much higher caspase-1 activation and
IL-1b secretion by macrophages than did wild-type bacteria.
Although it has been confirmed that mutants lacking either of
the above inflammasome-inhibiting virulence factors were atten-
uated in hosts, the exact mechanisms by which they affect in-
flammasome assembly and activation remain largely unknown.
What is apparent is that the dampening of inflammasome-
dependent activation of caspase-1 is a common strategy
employed by these pathogens to outsmart host defenses. The
resultant delay in host cell death provides thepathogenswith suf-
ficient time for intracellular replication and invasion of new cells.
Inflammasome Activation and Adaptive Immunity
The IL-1 family cytokines, IL-1, IL-18, and IL-33, play an impor-
tant role in modulating the adaptive immune response (Dunne
and O’Neill, 2003; Yoshimoto et al., 2000). Since the secretion
of these cytokines is promoted by inflammasome activation, it
is possible that the inflammasome also plays a role in shaping
the adaptive immune response. Support for this hypothesis
comes from studies in which ASC-, NLRP3-, and IL-1b-deficient
mice all showed impaired contact hypersensitivity (a T cell-medi-
ated cellular immune response to contact allergens) to trinitro-
phenylchloride (Shornick et al., 1996; Sutterwala et al., 2006).
Several groups recently investigated further how inflamma-
some activation might modulate the adaptive immune response.
Two studies by Eisenbarth et al. and Li et al. showed that alum
adjuvant activates NLRP3-dependent secretion of IL-1 family
cytokines and enhances the adaptive immune response (Eisen-
barth et al., 2008; Li et al., 2008), linking inflammasome activation
to alum adjuvanticity. However, it is less clear whether an IL-1ell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Inc. 203
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Four general mechanisms are involved in NLR-mediated inflammasome activation. (1) Pore formation: Toxins, translocon components of T3SS, T4SS, or possibly
T6SS, and ATP-P2X7R-activated pannexin-1 induce pore formation in the host membrane. Membrane damage caused by pore-forming factors induces or mod-
ifies an endogenous molecule that is recognized by NLRs. Alternatively, extracellularlly or endosomally located microbial molecules fortuitously gain access, via
these pores, to the host cell cytosol, where the inflammasome senses cytosolic microbial molecules or intermediary signals induced by these molecules. (2) K+
efflux: K+ efflux is required for the activation of both NLRP3 and NLRP1 inflammasomes but not NLRC4 inflammasome. Toxin-induced pore formation or ATP-
induced P2X7R (a purinergic receptor) activation induces K
+ efflux. Crystals induce K+ efflux by an unknown mechanism. (3) ROS production: ATP-mediated
P2X7R activation or phagocytosis of crystals induces ROS production, which in turn stimulates activation of the NLRP3 inflammasome. (4) Lysosome damage:
Phagocytosis of crystals induces lysosomal damage, leading to the release of cathepsin B, which in turn activates the NLRP3 inflammasome. These four mech-
anisms are not mutually exclusive, and depending on different stimuli, crosstalk among thesemechanismsmay occur to induce intermediary signals that activate
the inflammasome. NLRs, nucleotide-binding domain and leucine-rich repeat containing proteins, such as NLRP1, NLRP3, NLRC4, and NOD2.family cytokine is directly mediating the alum adjuvant-stimu-
lated adaptive immune responses. This can be seen by the
fact that MyD88 (myeloid differentiation primary response gene
88)-deficient mice exhibit no defect in antibody production or
TH2 response after alum priming despiteMyD88’s being a critical
component in the signaling cascademediated by the IL-1 recep-
tor and the IL-18 receptor (Adachi et al., 1998; Eisenbarth et al.,
2008). The findings from Eisenbarth et al. and Li et al. were partly
corroborated by Franchi and Nu´n˜ez, who demonstrated that
alum promotes caspase-1 activation and IL-1b secretion
through the NLRP3 inflammasome (Franchi and Nu´n˜ez, 2008).
However, unlike in the first two studies, Franchi and Nu´n˜ez
showed that the NLRP3 inflammasome is dispensable for alum
adjuvanticity. This discrepancy may have arisen from the use
of different experimental protocols between studies, and the
use of standardized and consistent immunization protocols will
clarify the role of the NLRP3 inflammasome in the alum
adjuvant-induced humoral responses. It is possible that different
stimuli may dictate whether or not certain inflammasomes
modulate the adaptive immune response.
General Mechanisms of Inflammasome Activation
The signaling networks that activate the inflammasome are
highly complex. Although the LRR domain of the NLR has
been suggested as the sensor of cytosolic ligands, direct inter-204 Cell Host & Microbe 4, September 11, 2008 ª2008 Elsevier Incaction between NLRs and PAMPs has never been demon-
strated. It is hence very likely that various stimuli induce certain
intermediary signals that directly or indirectly inhibit the folding
of the LRR domain toward the NOD domain, leading to the olig-
omerization and activation of NLR proteins. The general mecha-
nisms of inflammasome activation may include pore formation,
K+ effux, ROS production, and lysosome damage (Figure 2).
Pore Formation
As described earlier, pore formation can be induced by various
toxins (aerolysin, nigericin, maitotoxin, LLO, LT, and cytolysin)
or translocon components of T3SS, T4SS, and possibly T6SS.
There are two hypotheses for how pore formation induces
NLR-mediated inflammasome activation. The first is that mem-
brane damage caused by pore-forming factors induces or mod-
ifies an endogenous molecule that is recognized by NLRs. The
second is that extracellularly or endosomally located microbial
molecules, such as flagellin and MDP, could fortuitously gain
access, via these pores, to the host cell cytosol, where the in-
flammasome initiates a rapid response directly against cytosolic
microbial molecules or a signal induced by these molecules.
Interestingly, this pore formation model could also be applied
to pannexin-1, a plasma membrane- and phagosome-located
protein. Kanneganti et al. recently proposed that ATP- and
P2X7R-mediated activation of pannexin-1 could lead to pore for-
mation and mediate the delivery of microbial molecules into the.
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(Kanneganti et al., 2007a) (Figures 1 and 2).
K+ Efflux
Pore formation results in various cellular changes, one of which is
K+ efflux (Aroian and van der Goot, 2007), which is crucial for the
activation of both NLRP3 and NLRP1 inflammasomes (Pe´trilli
et al., 2007b). One exception is the NLRC4 inflammasome,
whose activation by S. typhimurium is independent of K+ (Fink
et al., 2008; Pe´trilli et al., 2007b).
ROS Production
Cruz et al. reported that the activation of the P2X7 receptor by
ATP induced the production of ROS which was then required
for downstream inflammasome activation (Cruz et al., 2007).
Similarly, asbestos- and MSU-mediated inflammasome activa-
tion was abolished in the presence of ROS inhibitors (Cassel
et al., 2008; Dostert et al., 2008). ROS could therefore serve as
a common signal to trigger inflammasome activation. Because
ROS are produced in response to various pathogens, it would
be interesting to determine whether ROS mediates the patho-
gen-triggered inflammasome activation.
Lysosome Damage
Recently, two groups provided new insights into how crystalline
structures can activate the inflammasome, by demonstrating
that silica crystals, aluminum salts, and fibrillar amyloid-b (Ab)
all activate the NLRP3 inflammasome in a similar manner (Halle
et al., 2008; Hornung et al., 2008). All of these crystalline struc-
tures cause lysosomal damage, upon which the release of ca-
thepsin B leads toNLRP3 inflammasomeactivation and IL-1b se-
cretion (Halle et al., 2008; Hornung et al., 2008). This observation
suggests that lysosomal damage induced by crystalline struc-
tures and the resultant release of cathepsin B serve as the critical
upstream signal that activates the NLRP3 inflammasome. It is in-
teresting to note that similar to amyloid beta, mutant NLRP3 also
results in the activation of cathepsin B (Willingham et al., 2007).
It should be noted that the four mechanisms involved in inflam-
masome activation that are mentioned here are not mutually
exclusive, and there could be significant crosstalk among the
pathways to induce intermediary signals that act on inflamma-
some components. The biggest challenge now is to understand
the link between these mechanisms and to identify the interme-
diary signals that directly activate the inflammasome.
Perspectives
There areover 20knownNLRs in thehumanandmousegenomes,
ofwhichonlyNLRP1,NLRP3,NLRC4,andNOD2havebeen inten-
sively analyzed in respect to their involvement in inflammasome
activation. In order to get a detailed understanding of inflamma-
some-mediated immune responses, it will be crucial to character-
ize other types of inflammasomes and uncover their roles in the
innate immune response using different NLR-deficient mice.
In an NLR, the LRR domain usually associates with the NOD
domain to prevent autoactivation of the inflammasome. It is
therefore possible that other intracellular proteins may regulate
inflammasome activation through their interactions with the
LRR domain. An attractive experimental approach would be to
use LRR domains as baits to identify endogenous LRR interac-
tion partners. Indeed, using a yeast two-hybrid assay, Mayor
et al. were able to show that the ubiquitin ligase-associated pro-
tein SGT1 and heat shock protein 90 (HSP90) interact with theLRR domain of NLRP3 and that they form a complex to maintain
NLRP3 in an inactive but signaling-competent state (Mayor et al.,
2007). In this postgenomic era, we can expect that more LRR-
interacting proteins will eventually be identified via various sensi-
tive proteomic techniques.
The concept of the inflammasome has been introduced for no
more than 10 years, andmost studies have focused on the role of
inflammasome activation in bacterial and viral infections. It is
conceivable that the inflammasome may also play a role in
host-parasite and host-fungus interactions. As the genomes of
various pathogens become available, it will be intriguing to sort
out the proteins that share similar structures to NLRs or known
inflammasome-inhibiting virulence factors, as well as to study
how these proteins could potentially interfere with inflamma-
some activation.
It should be noted that the inflammasome-dependent activa-
tion of caspase-1 acts as a double-edged sword for the host
and has broad biological implications. In vivo, caspase-1 activa-
tion protects the host against various pathogens, such as S.
typhimurium, S. flexneri, F. tularensis, L. monocytogenes, and
S. aureus (Lara-Tejero et al., 2006; Mariathasan et al., 2005;
Miller et al., 2007; Sansonetti et al., 2000; Tsuji et al., 2004). At
the same time, excessive caspase-1 activation can lead to sev-
eral inflammatory disorders, such as systemic juvenile idiopathic
arthritis, gout, and pseudogout diseases (Church et al., 2008).
Considering the fine line that the inflammasome straddles be-
tween benefiting and harming the host, it would be worthwhile
to develop small compounds that can interact specifically with
inflammasome components to modulate its activity to the host’s
benefit. An alternative strategy will be to target IL-1b to alleviate
IL-1b-mediated inflammatory disorders. This is already being
pursued, with IL-1b-targeting agents now either in clinical trials
or approved for the treatment of certain inflammatory disorders
(Church et al., 2008). Meanwhile, the ‘‘inflammasome-dampen-
ing’’ virulence factors all represent attractive drug targets for
new therapeutic approaches against pathogen infections. In
terms of vaccine development, the possible involvement of the
inflammasome in mediating the activity of aluminum adjuvants
will likely impact the designing of safer and more effective adju-
vants. Ultimately, the successful development of inflamma-
some-based therapeutics and vaccines will benefit immensely
from a greater understanding of the inflammasome activation
signaling pathways, as well as the biological significance of
caspase-1 activation.
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